Aton Ra Partners Pacific Biosciences Of California, Inc. Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 58,722 shares of PACB stock, worth $108,048. This represents 1.15% of its overall portfolio holdings.

Number of Shares

58,722

Previous 65,082 9.77%

Holding current value

$108,048

Previous $543,000 6.08%

% of portfolio

1.15%

Previous 1.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$5.97 - $10.36 $37,969 - $65,889	-6,360 Reduced 9.77%	58,722 $576,000
Q3 2023 Oct 25, 2023	BUY	$8.23 - $13.93 $20,607 - $34,880	2,504 Added 4.0%	65,082 $543,000
Q2 2023 Jul 18, 2023	SELL	$9.97 - $14.05 $138,114 - $194,634	-13,853 Reduced 18.12%	62,578 $832,000
Q1 2023 May 05, 2023	SELL	$7.94 - $12.02 $85,339 - $129,190	-10,748 Reduced 12.33%	76,431 $885,000
Q4 2022 Feb 02, 2023	SELL	$5.67 - $11.2 $243,027 - $480,054	-42,862 Reduced 32.96%	87,179 $713,000
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $54,638 - $119,148	-13,903 Reduced 9.66%	130,041 $755,000
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $340,654 - $883,838	84,740 Added 143.13%	143,944 $636,000
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $83,381 - $206,721	-9,891 Reduced 14.32%	59,204 $539,000
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $485,448 - $758,166	-25,205 Reduced 26.73%	69,095 $1.41 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $909,279 - $1.28 Million	36,576 Added 63.36%	94,300 $2.41 Million
Q2 2021 Aug 12, 2021	BUY	$22.3 - $36.02 $690,028 - $1.11 Million	30,943 Added 115.54%	57,724 $2.02 Million
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $706,482 - $1.37 Million	26,781 New	26,781 $892,000

Others Institutions Holding PACB

# of Institutions

255

Shares Held

233M

Call Options Held

971K

Put Options Held

965K

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $414M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account